GS3-007a

· Changchun GeneScience Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for GS3-007a, covering 2025-12-02 to 2025-12-04. Get the full timeline:

Most recent: Clinical Trial Update: A Study (Phase 1b/2) of GS3-007a Oral Treatment in Children With Growth Hormone Deficiency (PGHD) [Phase 1, Phase 2]

See pricing